• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析:一种带有非生物性液体的生物膜。

Peritoneal dialysis: a biological membrane with a nonbiological fluid.

作者信息

Witowski Janusz, Jörres Achim

出版信息

Contrib Nephrol. 2009;163:27-34. doi: 10.1159/000223777. Epub 2009 Jun 3.

DOI:10.1159/000223777
PMID:19494592
Abstract

During chronic peritoneal dialysis (PD), the peritoneal membrane undergoes structural and functional alterations that, in some patients, may eventually lead to loss of function as the 'dialysis membrane'. These alterations include loss of mesothelial cells, thickening of the submesothelial compact zone, and changes of vascularization. At least some of these effects are thought to be associated with chronic exposure to unphysiological PD fluids. On a cellular level, chronic PD is associated with the phenomenon of epithelial-to-mesenchymal transformation (EMT) as well as premature aging and senescence of mesothelial cells. The present article discusses the potential mechanisms involved in these phenomena and reviews the current information derived from cell culture and animal studies.

摘要

在慢性腹膜透析(PD)过程中,腹膜会发生结构和功能改变,在一些患者中,这些改变最终可能导致作为“透析膜”的功能丧失。这些改变包括间皮细胞丢失、间皮下致密层增厚以及血管化改变。至少其中一些影响被认为与长期接触非生理性腹膜透析液有关。在细胞水平上,慢性腹膜透析与上皮-间充质转化(EMT)现象以及间皮细胞过早衰老和衰老有关。本文讨论了这些现象所涉及的潜在机制,并综述了来自细胞培养和动物研究的当前信息。

相似文献

1
Peritoneal dialysis: a biological membrane with a nonbiological fluid.腹膜透析:一种带有非生物性液体的生物膜。
Contrib Nephrol. 2009;163:27-34. doi: 10.1159/000223777. Epub 2009 Jun 3.
2
[Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].[接受腹膜透析患者腹膜纤维化的选定指标]
Postepy Hig Med Dosw (Online). 2009 Apr 30;63:200-4.
3
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.过氧化物酶体增殖物激活受体-γ 激动剂罗格列酮可保护腹膜免受透析液损伤。
Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7.
4
Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.透析流出液来源间皮细胞的体外分析:一种揭示腹膜衰竭机制的方法
Perit Dial Int. 2006 Jan-Feb;26(1):26-34.
5
Peritoneal morphological and functional changes associated with platelet-derived growth factor B.与血小板源性生长因子B相关的腹膜形态和功能变化。
Nephrol Dial Transplant. 2009 Feb;24(2):448-57. doi: 10.1093/ndt/gfn498. Epub 2008 Sep 4.
6
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.腹膜透析患者的上皮-间质转化与腹膜功能衰竭:病理意义及潜在治疗干预措施
J Am Soc Nephrol. 2007 Jul;18(7):2004-13. doi: 10.1681/ASN.2006111292. Epub 2007 Jun 13.
7
Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.间皮细胞的上皮-间质转化是腹膜透析过程中的早期事件,且与高腹膜转运相关。
Kidney Int Suppl. 2008 Apr(108):S26-33. doi: 10.1038/sj.ki.5002598.
8
Mediators of inflammation and fibrosis.炎症和纤维化的介质。
Perit Dial Int. 2007 Jun;27 Suppl 2:S65-71.
9
Mechanisms of cell death during peritoneal dialysis. A role for osmotic and oxidative stress.
Contrib Nephrol. 2009;163:35-44. doi: 10.1159/000223778. Epub 2009 Jun 3.
10
Morpho-functional study of peritoneum in peritoneal dialysis patients.腹膜透析患者腹膜的形态功能研究
J Nephrol. 2003 May-Jun;16(3):373-8.

引用本文的文献

1
Increased storage and secretion of phosphatidylcholines by senescent human peritoneal mesothelial cells.衰老的人腹膜间皮细胞中磷脂酰胆碱的储存和分泌增加。
Clin Exp Nephrol. 2016 Aug;20(4):544-551. doi: 10.1007/s10157-015-1192-1. Epub 2015 Nov 2.
2
Peritoneal dialysis tailored to pediatric needs.根据儿童需求定制的腹膜透析。
Int J Nephrol. 2011;2011:940267. doi: 10.4061/2011/940267. Epub 2011 Jun 8.
3
Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group.儿童腹膜透析解决方案:欧洲儿科透析工作组的建议。
Pediatr Nephrol. 2011 Jul;26(7):1137-47. doi: 10.1007/s00467-011-1863-4. Epub 2011 Mar 31.
4
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.慢性腹膜透析中无需设置“有效期”来预防包裹性腹膜硬化。
Int Urol Nephrol. 2009 Dec;41(4):903-7. doi: 10.1007/s11255-009-9661-7.